Ikegami H - Search Results

1

Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).

Katsuno T, Shiraiwa T, Iwasaki S, Park H, Watanabe N, Kaneko S, Terasaki J, Hanafusa T, Imagawa A, Shimomura I, Ikegami H, Koyama H, Namba M, Miyagawa JI; TRUST2 study group. Katsuno T, et al. Among authors: ikegami h. Adv Ther. 2021 Mar;38(3):1514-1535. doi: 10.1007/s12325-021-01631-y. Epub 2021 Jan 28. Adv Ther. 2021. PMID: 33507500 Clinical Trial.

2

[Clinical heterogeneity in elderly patients with diabetes mellitus].

Fujisawa T, Ikegami H, Ogihara T. Fujisawa T, et al. Among authors: ikegami h. Nihon Ronen Igakkai Zasshi. 2002 Jul;39(4):390-2. doi: 10.3143/geriatrics.39.390. Nihon Ronen Igakkai Zasshi. 2002. PMID: 12187800 Free article. Japanese.

3

Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones.

Ono M, Ikegami H, Fujisawa T, Nojima K, Kawabata Y, Nishino M, Taniguchi H, Itoi-Babaya M, Babaya N, Inoue K, Ogihara T. Ono M, et al. Among authors: ikegami h. Metabolism. 2005 Apr;54(4):529-32. doi: 10.1016/j.metabol.2004.11.007. Metabolism. 2005. PMID: 15798962

4

The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese.

Asano K, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Hiromine Y, Ogihara T. Asano K, et al. Among authors: ikegami h. Ann N Y Acad Sci. 2006 Oct;1079:47-50. doi: 10.1196/annals.1375.007. Ann N Y Acad Sci. 2006. PMID: 17130531 Review.

5

A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region.

Kawabata Y, Ikegami H, Fujisawa T, Noso S, Asano K, Hiromine Y, Ogihara T. Kawabata Y, et al. Among authors: ikegami h. Ann N Y Acad Sci. 2006 Oct;1079:278-84. doi: 10.1196/annals.1375.042. Ann N Y Acad Sci. 2006. PMID: 17130566

6

Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibility.

Hiromine Y, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Yamaji K, Asano K, Ogihara T. Hiromine Y, et al. Among authors: ikegami h. Ann N Y Acad Sci. 2006 Oct;1079:285-8. doi: 10.1196/annals.1375.043. Ann N Y Acad Sci. 2006. PMID: 17130567

7

Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.

Kobayashi M, Ikegami H, Fujisawa T, Nojima K, Kawabata Y, Noso S, Babaya N, Itoi-Babaya M, Yamaji K, Hiromine Y, Shibata M, Ogihara T. Kobayashi M, et al. Among authors: ikegami h. Diabetes. 2007 Jan;56(1):239-47. doi: 10.2337/db06-0353. Diabetes. 2007. PMID: 17192488

8

Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese population.

Noso S, Fujisawa T, Kawabata Y, Asano K, Hiromine Y, Fukai A, Ogihara T, Ikegami H. Noso S, et al. Among authors: ikegami h. J Clin Endocrinol Metab. 2007 Jun;92(6):2358-62. doi: 10.1210/jc.2007-0031. Epub 2007 Mar 20. J Clin Endocrinol Metab. 2007. PMID: 17374705

9

Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.

Asano K, Ikegami H, Fujisawa T, Nishino M, Nojima K, Kawabata Y, Noso S, Hiromine Y, Fukai A, Ogihara T. Asano K, et al. Among authors: ikegami h. Hum Immunol. 2007 May;68(5):384-91. doi: 10.1016/j.humimm.2007.01.009. Epub 2007 Feb 21. Hum Immunol. 2007. PMID: 17462506

10

Present state of diabetes management in the elderly, Japan.

Fujisawa T, Ikegami H, Nojima K, Kawabata Y, Noso S, Asano K, Hiromine Y, Fukai A, Shindo N, Ogihara T. Fujisawa T, et al. Among authors: ikegami h. Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S82-6. doi: 10.1016/j.diabres.2007.01.038. Epub 2007 Apr 30. Diabetes Res Clin Pract. 2007. PMID: 17467841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

707 results

Search Page